Phreesia (PHR)
NYSE Market Open
Phreesia, Inc. provides a healthcare technology platform that helps medical organizations manage patient intake, engagement, payments, and administrative workflows. Its software is designed to sit inside the day-to-day operations of physician practices, health systems, hospitals, and other care settings, giving providers tools to communicate with patients before, during, and after visits. The platform supports tasks such as digital registration, appointment-related outreach, consent collection, insurance and demographic updates, payment capture, and patient education.
The company focuses on three broad areas of friction in healthcare: access to care, the affordability and collection of patient payments, and the ability to influence health outcomes through timely engagement. By digitizing steps that were historically handled through paper forms, phone calls, or manual front-desk processes, Phreesia aims to reduce administrative burden for providers and improve the patient experience. Its services are particularly relevant as healthcare organizations seek to modernize workflows while managing staffing pressure and rising operating complexity.
Phreesia also works with life sciences companies, public health organizations, patient advocacy groups, government entities, and not-for-profit organizations. These customers can use the platform to deliver targeted educational messages, surveys, and other engagement programs to patients in a clinical context. The business therefore combines software-as-a-service, payments, and healthcare communications capabilities, positioning Phreesia at the intersection of digital health infrastructure, provider operations, and patient activation.
Last updated
- Market Cap
- 596.48M
- P/E
- 64.96
- P/FCF
- 7.85
- P/S
- 1.2
- Enterprise Value
- 612.38M
- Sector
- Industrials
- Industry
- Business Services, Not Elsewhere Classified
- Address
- 1521 CONCORD PIKE, WILMINGTON, DE, 19803
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR
Robbins LLP Urges PHR Stockholders Who Lost Money Investing in Phreesia, Inc. to Contact the Firm for Information About Leading the Class Action
REMINDER: Phreesia, Inc. Investors With Significant Losses Must Act By July 13, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages FS KKR Capital Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FSK
PHR Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Phreesia, Inc. Class Action Lawsuit
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PHR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026
Phreesia Hits Bottom in Q1: Rebound Ahead, Timing Uncertain
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
5 Medical Info Systems Stock to Buy for a Stable Portfolio
Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks
Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Stock Market News for Mar 18, 2024
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 596.48M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 612.38M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 64.96
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.66
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.2
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 15.94
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.24
- EPS
- 0.15
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 7.85
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 6.79
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 75.98M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 2.56%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.38%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.25
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.54
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.54
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.49
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 1.62M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 9.65
Income Statement
| Line Item | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Revenue | 130.94M | 127.07M | 120.33M | 117.26M | 115.94M |
| Gross profit | 113.28M | 108.08M | 102M | 99.86M | 99.3M |
| Operating income | 6.75M | -5.56M | 3.74M | -1.51M | -3.29M |
| EBITDA | 16.7M | 4.24M | 11.33M | 6.14M | 3.59M |
| Net income | 2.96M | 1.3M | 4.27M | 654K | -3.91M |
| Basic EPS | 0.05 | 0.02 | 0.07 | 0.01 | -0.07 |
| Diluted EPS | 0.05 | 0.02 | 0.07 | 0.01 | -0.07 |
Balance Sheet
| Line Item | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total assets | 666.14M | 663.79M | 423.47M | 408.63M | 400.4M |
| Total liabilities | 307.05M | 326.58M | 103.14M | 110.64M | 118.21M |
| Total equity | 359.09M | 337.21M | 320.33M | 297.99M | 282.19M |
| Cash & equivalents | 74.71M | 73.83M | 106.37M | 98.27M | 90.87M |
| Current assets | 234.54M | 246.84M | 215.52M | 193.77M | 182.4M |
| Current liabilities | 152.11M | 183.24M | 98.78M | 105.14M | 110.72M |
Cash Flow
| Line Item | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 23.92M | 33.66M | 15.47M | 14.84M | 14.85M |
| Investing cash flow | 4.8M | -142.62M | -6.67M | -5.2M | -7.39M |
| Financing cash flow | -26.09M | 76.51M | -667K | -2.15M | -838K |
| Change in cash | 2.57M | -32.54M | 8.11M | 7.4M | 6.65M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 10-Q — Phreesia, Inc. | View Filing | |
| edgar index | 8-K — Phreesia, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 144 — Phreesia, Inc. | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| edgar index | DEF 14A — Phreesia, Inc. | View Filing | |
| edgar index | DEFA14A — Phreesia, Inc. | View Filing | |
| edgar index | ARS — Phreesia, Inc. | View Filing | |
| edgar index | 8-K — Phreesia, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Munson Gillian | View Filing | |
| form 4 | Form 4 — Goldstein Lainie | View Filing | |
| form 4 | Form 4 — CAHILL EDWARD L | View Filing | |
| edgar index | SCHEDULE 13G — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 144 — Phreesia, Inc. | View Filing | |
| form 4 | Form 4 — Hoffman Allison C | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 144 — Phreesia, Inc. | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| edgar index | 144 — Phreesia, Inc. | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 144 — Phreesia, Inc. | View Filing | |
| edgar index | 144 — Phreesia, Inc. | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — Hoffman Allison C | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — VanDuyn Amy Beth | View Filing | |
| form 4 | Form 4 — Roberts Evan | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| form 4 | Form 4 — Indig Chaim | View Filing | |
| form 4 | Form 4 — Indig Chaim | View Filing | |
| form 4 | Form 4 — Hoffman Allison C | View Filing | |
| form 4 | Form 4 — Gandhi Balaji | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 4 — Phreesia, Inc. | View Filing | |
| edgar index | 3 — Phreesia, Inc. | View Filing | |
| form 4 | Form 4 — Kessler Jon | View Filing | |
| form 4 | Form 4 — Kessler Jon | View Filing | |
| form 4 | Form 4 — Gandhi Balaji | View Filing | |
| form 4 | Form 4 — Hoffman Allison C | View Filing | |
| form 4 | Form 4 — Hui Yvonne | View Filing | |
| form 4 | Form 4 — Indig Chaim | View Filing | |
| form 4 | Form 4 — Indig Chaim | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — Linetsky David | View Filing | |
| form 4 | Form 4 — Roberts Evan | View Filing | |
| form 4 | Form 4 — VanDuyn Amy Beth | View Filing |